Results 261 to 270 of about 16,072,038 (292)
Some of the next articles are maybe not open access.
HDL-C: Role as a risk modifier
Atherosclerosis Supplements, 2011Evidence that low-density lipoprotein-cholesterol (LDL-C) causes cardiovascular disease (CVD) is overwhelming. It has also been proven beyond all doubt that lowering the level of LDL-C using statins reduces CV risk. However, many people remain at high risk even when their level of LDL-C has been reduced by aggressive treatment with statins.
openaire +2 more sources
Biomarkers in Medicine, 2023
Aim: The study sought to investigate the association of non-high-density-lipoprotein cholesterol-to-high-density-lipoprotein cholesterol ratio (NON-HDL-C:HDL-C) with coronary lesions and major adverse cardiovascular events (MACE) in first-onset non-ST-segment elevation acute myocardial infarction.
Qi Mao, Jianhua Zhao, Xiaohui Zhao
openaire +2 more sources
Aim: The study sought to investigate the association of non-high-density-lipoprotein cholesterol-to-high-density-lipoprotein cholesterol ratio (NON-HDL-C:HDL-C) with coronary lesions and major adverse cardiovascular events (MACE) in first-onset non-ST-segment elevation acute myocardial infarction.
Qi Mao, Jianhua Zhao, Xiaohui Zhao
openaire +2 more sources
Climacteric, 2019
Background: A novel lipid relation, the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (non-HDL-C/HDL-C) ratio gathers information on all atherogenic and antiatherogenic particles on a single date. The relationship between this lipid marker and the presence of carotid atherosclerotic plaque (CAP) in postmenopausal ...
W, Masson +5 more
openaire +2 more sources
Background: A novel lipid relation, the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (non-HDL-C/HDL-C) ratio gathers information on all atherogenic and antiatherogenic particles on a single date. The relationship between this lipid marker and the presence of carotid atherosclerotic plaque (CAP) in postmenopausal ...
W, Masson +5 more
openaire +2 more sources
Different association of HDL-C, apoA-I, and HDL-C/apoA-I with multiple outcomes in HFrEF patients
International Journal of CardiologyHigh-density lipoprotein-cholesterol (HDL-C) has been considered a cardioprotective factor for several decades. However, its association with outcomes in patients with heart failure with reduced ejection fraction (HFrEF) remains controversial. We aimed to investigate the association of HDL-C, apolipoprotein A-I (apoA-I), and the HDL-C/apoA-I ratio with
Ayiguli, Abudukeremu +13 more
openaire +2 more sources
Postgraduate Medicine, 2005
Although statin therapy has revolutionized management of coronary heart disease (CHD), the lowering of low-density lipoprotein cholesterol (LDL-C) levels is not the whole story. Increased plasma concentrations of high-density lipoprotein cholesterol (HDL-C) have a cardioprotective effect that is just as important for reducing risk of heart attack and ...
openaire +2 more sources
Although statin therapy has revolutionized management of coronary heart disease (CHD), the lowering of low-density lipoprotein cholesterol (LDL-C) levels is not the whole story. Increased plasma concentrations of high-density lipoprotein cholesterol (HDL-C) have a cardioprotective effect that is just as important for reducing risk of heart attack and ...
openaire +2 more sources
THE ACUTE EFFECTS OF EXERCISE AT DIFFERENT INTENSITIES ON HDL-C AND HDL-C SUDFRACTIONS
Medicine & Science in Sports & Exercise, 1992P. M. Gordon +6 more
openaire +1 more source
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research
Circulation, 2021Anand Rohatgi +2 more
exaly
HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy
Circulation Research, 2023Macrae F Linton +2 more
exaly
Metabolic Determinants of Low HDL‐C Levels
Annals of the New York Academy of Sciences, 1993J L, Breslow, S, Eisenberg, E A, Brinton
openaire +2 more sources